Skip to main content

Table 3 Incidence rate (IR) of cardiovascular disease eventsa (CVDe) among persons living with HIV exposed to abacavir for various durations

From: Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study

Duration of exposure to abacavir (months) Person-years No. of CVDe Incidence rate per 1000 people (95% CI)
Never exposed 98,857 561 5.68 (5.22, 6.16)
1–6 4757 51 10.72 (8.15, 14.11)
7–12 3125 31 9.92 (6.98, 14.11)
13–18 2208 25 11.32 (7.65, 16.76)
19–24 1663 18 10.82 (6.82, 17.18)
>25 3860 28 7.25 (5.01, 10.51)
  1. aIncludes acute myocardial infarction and coronary intervention procedures